Journal of Medicine and Philosophy 26 (3):273 – 284 (2001)

Abstract
The biotechnology patent debates have revealed deep moral concerns about basic genetics research, RD and specific biotechnological products, concerns that are seldom taken into consideration in Technology Assessment. In this paper important moral concerns are examined which appear at the various stages of development of a specific genetic product: a predictive genetic test. The purpose is to illustrate the need for a more contextual approach in technology assessment, which integrates the various forms of interaction between bio-technology and society or societal segments. Such an approach will generate greater insight in the moral issues at all stages of a products life-cycle and this will facilitate decision-making on the morality of a specific biotechnological product.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1076/jmep.26.3.273.3017
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 70,214
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

The Case for Regulating Intragenic GMOs.A. Wendy Russell & Robert Sparrow - 2008 - Journal of Agricultural and Environmental Ethics 21 (2):153-181.

Add more citations

Similar books and articles

Analytics

Added to PP index
2009-01-28

Total views
26 ( #439,144 of 2,507,562 )

Recent downloads (6 months)
1 ( #416,983 of 2,507,562 )

How can I increase my downloads?

Downloads

My notes